Results 241 to 250 of about 33,549 (305)
Shear‐induced blood damage—including hemolysis, platelet and neutrophil injury, and von Willebrand factor (vWF) degradation—was evaluated for the BrioVAD and HM3 using an in vitro circulatory loop under clinically relevant conditions. Across 15 biomarkers (n > 6 per group), no significant differences were observed between the two devices.
Wenji Sun +9 more
wiley +1 more source
Implantation of a Left Ventricular Assist Device With Concomitant Repair of Ascending Aortic Aneurysm. [PDF]
Rajah T +3 more
europepmc +1 more source
This mixed methods study aimed to: (i) identify treatment expectations held by individuals with a ventricular assist device (VAD), (ii) assess the extent to which these expectations have been met, and (iii) examine how treatment expectations relate to VAD‐specific health‐related quality of life (HRQoL) ABSTRACT Objectives Treatment expectations ...
Simon Felix Zerth +10 more
wiley +1 more source
Perioperative management and outcomes of hip and knee arthroplasty among heartmate 3 left ventricular assist device recipients. [PDF]
Turan O +6 more
europepmc +1 more source
Blade shapes (leading‐edge geometry and thickness) in rotodynamic blood pumps were systematically evaluated. Thinner blades improve pump efficiency by reducing blockage effects, while neither blade thickness nor leading‐edge geometry shows clear hemocompatibility benefits. Overall, blade shape has a limited impact on hemocompatibility, indicating it is
Benjamin Torner +7 more
wiley +1 more source
Percutaneous extracorporeal ventricular assist device as a successful bridge strategy to durable left ventricular assist device in refractory cardiogenic shock: a case report. [PDF]
Li D, Chen J, Liu J, Zhao J.
europepmc +1 more source
Background and Purpose The pathogenesis of type 2 diabetes mellitus (T2DM)‐induced cardiomyopathy involves cardiac fibrosis that leads to diastolic dysfunction. We established that replacement of lost substance P (SP) that occurs in T2DM reduces cardiac fibrosis and decreases inflammation in T2DM mice and non‐human primates.
Alexander Widiapradja +11 more
wiley +1 more source
The Impact of Obesity on Durable Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis. [PDF]
Jacobs H +11 more
europepmc +1 more source
Abstract Background and Purpose Aberrant activation of type 2 ryanodine receptors (RyR2) causes lethal arrhythmias, such as catecholaminergic polymorphic ventricular tachycardia (CPVT). Developing drugs that suppress RyR2 hyperactivation may be key to novel arrhythmia treatments.
Nagomi Kurebayashi +29 more
wiley +1 more source
Study of the energy efficiency of various drive systems of an innovative implantable left ventricular assist device. [PDF]
Jasinski R +3 more
europepmc +1 more source

